1R.Dumke,H.Von Baum,P.C.Lück,E.Jacobs.Occurrence of macrolide‐resistant Mycoplasma pneumoniae strains in Germany[J]. Clinical Microbiology and Infection . 2010 (6)
2KoichiSuzuki,KojiHirano,NorioOnodera,ToruTakahashi,HiroshiTanaka.Acute IgA nephropathy associated with mycoplasma pneumoniae infection[J]. Pediatrics International . 2005 (5)
3Norio Okazaki,Mitsuo Narita,Satoshi Yamada,Kinichi Izumikawa,Masao Umetsu,Tsuyoshi Kenri,Yuko Sasaki,Yoshichika Arakawa,Tsuguo Sasaki.Characteristics of Macrolide‐Resistant Mycoplasma pneumoniae Strains Isolated from Patients and Induced with Erythromycin In Vitro[J]. Microbiology and Immunology . 2001 (8)
4Okazaki Norio,Ohya Hitomi,Sasaki Tuguo.Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains. Japanese journal of infectious diseases . 2007
5Morozumi Miyuki,Iwata Satoshi,Hasegawa Keiko,Chiba Naoko,Takayanagi Reiko,Matsubara Keita,Nakayama Eiichi,Sunakawa Keisuke,Ubukata Kimiko.Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy . 2007
6Pereyre S,Charron A,Renaudin H,Bébéar C,Bébéar C M.First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. Journal of Clinical Microbiology . 2007
7Wolff Bernard J,Thacker W Lanier,Schwartz Stephanie B,Winchell Jonas M.Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrobial Agents and Chemotherapy . 2008
8Smith C B,Friedewald W T,Chanock R M.Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. The New England Quarterly . 1967
9Naoyuki Miyashita,Yasuhiro Kawai,Hiroto Akaike,Kazunobu Ouchi,Toshikiyo Hayashi,Takeyuki Kurihara,Niro Okimoto,the Atypical Pathogen Study Group.Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infectious Diseases . 2012
10Foy H M,Grayston J T,Kenny G E,Alexander E R,McMahan R.Epidemiology of Mycoplasma pneumoniae infection in families. JAMA : the journal of the American Medical Association . 1966
5Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with Erythromycin in Vitro. Microbiol Immunol, 2001,45:617-620.
6Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother, 2004,48:4624-4630.
7Patrick R, Murra Y, Elle JO, et al. Manual of Clinical Microbiology. 8th ed. Washington DC : ASM Press, 2003 : 288- 304.
8Gabashvili IS, Gregory ST, Valle M, et al. The polypeptide tunnel system in the ribosomal and its gating in the erythromycin resistance mutants of L4 and L22. Mol Cell,2001,8:181-188.
9Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother, 2001, 45 : 1-12.
10Weisblum B. Erythromycin resistance by ribosom modification. Antimicrob Agents Chemother, 1995,39:577-585.
